Ranked All-Publication list   Historiographs Glossary  HistCite Guide  About
Fri Aug 4 16:36:35 2006

Complete replication of hepatitis C virus in cell culture
Lindenbach BD, Evans MJ, Syder AJ, et al.
SCIENCE 309 (5734): 623-626 JUL 22 2005
and the citing papers
Nodes: 75, Authors: 371, Journals: 31, Cited References: 2431, Words: 336
Yearly output  |  Document Type  |  Language  |  Institution  |  Institution with Subdivision  |  Country
Collection span: 2005 - 2006
View: Overview   Sorted by first author.

#LCRNCRNode / Date / Journal / AuthorLCSGCS
112249 2006 JOURNAL OF GENERAL VIROLOGY 87: 855-860
Ait-Goughoulte M; Hourioux C; Patient R; Trassard S; Brand D; et al.
Core protein cleavage by signal peptide peptidase is required for hepatitis C virus-like particle assembly
00
226345 2006 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (15): 9833-9836
Appel N; Schaller T; Penin F; Bartenschlager R
From structure to function: New insights into hepatitis C virus RNA replication
00
34723 2005 HEPATOLOGY 42 (6): 1264-1269
Berke JM; Moradpour D
Hepatitis C virus comes full circle: Production of recombinant infectious virus in tissue culture
12
414764 2006 JOURNAL OF VIROLOGY 80 (10): 4940-4948
Bertaux C; Dragic T
Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry
00
545966 2006 JOURNAL OF VIROLOGY 80 (14): 6964-6972
Blanchard E; Belouzard S; Goueslain L; Wakita T; Dubuisson J; et al.
Hepatitis C virus entry depends on clathrin-mediated endocytosis
00
613255 2006 JOURNAL OF MEDICINAL CHEMISTRY 49 (9): 2750-2757
Bogen SL; Arasappan A; Bennett F; Chen K; Jao E; et al.
Discovery of SCH446211 (SCH6): A new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication
00
722371 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (10): 3500-3501
Bukh J; Purcell RH
A milestone for hepatitis C virus research: A virus generated in cell culture is fully viable in vivo
00
814410 2005 JOURNAL OF VIROLOGY 79 (22): 13963-13973
Cai ZH; Zhang C; Chang KS; Jiang JY; Ahn BC; et al.
Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells
22
913550 2006 JOURNAL OF GENERAL VIROLOGY 87: 861-871
Chapel C; Garcia C; Roingeard P; Zitzmann N; Dubuisson J; et al.
Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles
00
1022874 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (22): 8499-8504
Cheng G; Zhong J; Chisari FV
Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
1113912 2005 NATURE 436 (7053): 930-932
Chisari FV
Unscrambling hepatitis C virus-host interactions
39
1219451 2006 JOURNAL OF GENERAL VIROLOGY 87: 1075-1084
Cocquerel L; Voisset C; Dubuisson J
Hepatitis C virus entry: potential receptors and their biological functions
00
1325532 2006 EUROPEAN JOURNAL OF IMMUNOLOGY 36 (4): 919-929
Crotta S; Ronconi V; Ulivieri C; Baldari CT; Valiente NM; et al.
Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells
00
141594 2005 JOURNAL OF BIOLOGICAL CHEMISTRY 280 (48): 39802-39808
Domitrovich AM; Felmlee DJ; Siddiqui A
Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion
00
1542739 2006 HEPATOLOGY 43 (5): 903-905
Dreux M; Cosset FL
HCV and lipoproteins: Is oxLDL an Achilles' heel of the Trojan horse?
00
1627846 2006 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (27): 18285-18295
Dreux M; Pietschmann T; Granier C; Voisset C; Ricard-Blum S; et al.
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI
00
1726841 2006 HEPATOLOGY 43 (6): 1326-1336
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; et al.
Host cell responses induced by hepatitis C virus binding
00
1819115 2005 NATURE 436 (7053): 967-972
Feld JJ; Hoofnagle JH
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
315
1912217 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (49): 17539-17540
Freundt EC; Lenardo MJ
Interfering with interferons: Hepatitis C virus counters innate immunity
02
2017543 2006 INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 20 (1): 81-+
Glenn JS
Molecular virology of the hepatitis C virus: Implication for novel therapies
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
2118275 2006 REVIEWS IN MEDICAL VIROLOGY 16 (1): 37-48
Graci JD; Cameron CE
Mechanisms of action of ribavirin against distinct viruses
00
2214611 2005 JOURNAL OF VIROLOGY 79 (24): 15525-15536
Griffin S; Clarke D; McCormick C; Rowlands D; Harris M
Signal peptide cleavage and internal targeting signals direct the hepatitis C virus p7 protein to distinct intracellular membranes
00
2349734 2006 GENE THERAPY 13 (6): 563-575
Grimm D; Kay MA
Therapeutic short hairpin RNA expression in the liver: viral targets and vectors
00
2417214 2005 NATURE 436 (7053): 961-966
Houghton M; Abrignani S
Prospects for a vaccine against the hepatitis C virus
16
2522642 2006 HEPATOLOGY 44 (1): 117-125
Ikeda M; Abe K; Yamada M; Dansako H; Naka K; et al.
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
00
2623462 2006 JOURNAL OF VIROLOGY 80 (9): 4510-4520
Ishii N; Watashi K; Hishiki T; Goto K; Inoue D; et al.
Diverse effects of cyclosporine on hepatitis C virus strain replication
00
2717768 2006 NUCLEIC ACIDS RESEARCH 34 (9): 2618-2633
Ivanyi-Nagy R; Kanevsky I; Gabus C; Lavergne JP; Ficheux D; et al.
Analysis of hepatitis C virus RNA dimerization and core-RNA interactions
00
281621 2005 SCIENTIST 19 (17): 29-30
Jonietz E
How does your virus grow?
00
2933363 2006 JOURNAL OF VIROLOGY 80 (9): 4633-4639
Kanda T; Basu A; Steele R; Wakita T; Ryerse JS; et al.
Generation of infectious hepatitis C virus in immortalized human hepatocytes
00
301345 2005 JOURNAL OF CLINICAL MICROBIOLOGY 43 (11): 5679-5684
Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; et al.
Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system
11
#LCRNCRNode / Date / Journal / AuthorLCSGCS
3115159 2006 JOURNAL OF VIROLOGY 80 (4): 1817-1825
Kobayashi M; Bennett MC; Bercot T; Singh IR
Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay
00
3217553 2006 JOURNAL OF MEDICINAL CHEMISTRY 49 (5): 1693-1705
Koch U; Attenni B; Malancona S; Colarusso S; Conte I; et al.
2-(2-thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: Discovery, SAR, modeling, and mutagenesis
00
3325665 2006 JOURNAL OF VIROLOGY 80 (11): 5308-5320
Koutsoudakis G; Kaul A; Steinmann E; Kallis S; Lohmann V; et al.
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
00
3425323 2006 AMERICAN JOURNAL OF PATHOLOGY 169 (1): 200-208
Lai WK; Sun PJ; Zhang J; Jennings A; Lalor PF; et al.
Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium - A role for capturing hepatitis C virus particles
00
3526644 2006 JOURNAL OF BIOLOGICAL CHEMISTRY 281 (7): 3909-3917
Lavillette D; Bartosch B; Nourrisson D; Verney G; Cosset FL; et al.
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes
33
361648 2005 JOURNAL OF IMMUNOLOGY 175 (12): 8226-8235
Lee SH; Kim YK; Kim CS; Seol SK; Kim J; et al.
E2 of hepatitis C virus inhibits apoptosis
12
3724926 2006 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 50 (5): 1813-1822
Lin K; Perni RB; Kwong AD; Lin C
VX-950, a novel hepatitis C virus (HCV) NS34A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells
00
38110013 2005 NATURE 436 (7053): 933-938
Lindenbach BD; Rice CM
Unravelling hepatitis C virus replication from genome to function
715
3902720 2005 SCIENCE 309 (5734): 623-626
Lindenbach BD; Evans MJ; Syder AJ; Wolk B; Tellinghuisen TL; et al.
Complete replication of hepatitis C virus in cell culture
7474
4032772 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (10): 3805-3809
Lindenbach BD; Meuleman P; Ploss A; Vanwolleghem T; Syder AJ; et al.
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
22
#LCRNCRNode / Date / Journal / AuthorLCSGCS
4113148 2006 JOURNAL OF GENERAL VIROLOGY 87: 323-327
Liu SH; Ansari IH; Das SC; Pattnaik AK
Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication
00
4211919 2005 REVIEWS IN MEDICAL VIROLOGY 15 (6): 349-350
Mahy BWJ
Therapeutic RNA?
00
4314233 2006 FASEB JOURNAL 20 (2)
Maillard P; Huby T; Andreo U; Moreau M; Chapman J; et al.
The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins
00
4414925 2006 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 50 (3): 1013-1020
Malcolm BA; Liu R; Lahser F; Agrawal S; Belanger B; et al.
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells
00
4514529 2006 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 340 (1): 200-208
Matsuo E; Tani H; Lim CK; Komoda Y; Okamoto T; et al.
Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus
00
4615752 2006 JOURNAL OF HEPATOLOGY 44 (2): 411-421
McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practice
01
4713216 2005 NATURE 437 (7062): 1167-1172
Meylan E; Curran J; Hofmann K; Moradpour D; Binder M; et al.
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
641
4829867 2006 MOLECULAR CELL 22 (5): 561-569
Meylan E; Tschopp J
Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses
00
491161 2005 AMERICAN JOURNAL OF PATHOLOGY 167 (5): 1189-1191
Moore K; Dusheiko G
Opiate abuse and viral replication in hepatitis C
00
5013630 2006 CURRENT OPINION IN GASTROENTEROLOGY 22 (3): 193-197
Moseley RH
Liver and biliary tract disorders
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
5114836 2006 HEPATOLOGY 43 (2): 257-265
Nahmias Y; Casali M; Barbe L; Berthiaume F; Yarmush ML
Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles in primary rat and human hepatocytes
00
5213357 2006 JOURNAL OF VIROLOGY 80 (3): 1181-1190
Nelson HB; Tang HL
Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression
01
5314638 2006 HEPATOLOGY 43 (4): 761-770
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; et al.
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro
00
5415556 2006 JOURNAL OF VIROLOGY 80 (1): 149-160
Paeshuyse J; Leyssen P; Mabery E; Boddeker N; Vrancken R; et al.
A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase
11
55110535 2006 HEPATOLOGY 43 (2): S207-S220
Pawlotsky JM
Therapy of hepatitis C: From empiricism to eradication
00
561317 2005 JOURNAL OF HEPATOLOGY 43 (4): 553-555
Perelson AS; Ribeiro RM
Mutagenic effects of ribavirin in vivo
02
5733573 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (19): 7408-7413
Pietschmann T; Kaul A; Koutsoudakis G; Shavinskaya A; Kallis S; et al.
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
00
581819 2005 JOURNAL OF VIROLOGY 79 (21): 13594-13605
Quinkert D; Bartenschlager R; Lohmann V
Quantitative analysis of the hepatitis C virus replication complex
14
5941831 2006 EMBO REPORTS 7 (1): 14-17
Rinaldi A
The phantom menace
00
6026669 2006 ONCOGENE 25 (27): 3857-3865
Romano PR; McCallus DE; Pachuk CJ
RNA interference-mediated prevention and therapy for hepatocellular carcinoma
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
6113418 2005 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 102 (51): 18544-18549
Rosa D; Saletti G; De Gregorio E; Zorat F; Comar C; et al.
Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
12
6214460 2006 JOURNAL OF VIROLOGY 80 (6): 2832-2841
Rouille Y; Helle F; Delgrange D; Roingeard P; Voisset U; et al.
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus
11
631556 2005 JOURNAL OF GENERAL VIROLOGY 86: 3189-3199
Sandrin V; Boulanger P; Penin F; Granier C; Cosset FL; et al.
Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins
12
6416822 2005 TRENDS IN MICROBIOLOGY 13 (11): 528-534
Seeger C
Salient molecular features of hepatitis C virus revealed
11
6527261 2006 JOURNAL OF VIROLOGY 80 (7): 3332-3340
Shimakami T; Honda M; Kusakawa T; Murata T; Shimotohno K; et al.
Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon
00
6614547 2006 JOURNAL OF CLINICAL VIROLOGY 36 (2): 87-94
Stauber RE; Stadlbauer V
Novel approaches for therapy of chronic hepatitis C
00
671102 2005 CHEMISTRY & INDUSTRY (18): 22-24
Strosberg D; Burnet M
The molecular approach
00
6825754 2006 JOURNAL OF MEDICINAL CHEMISTRY 49 (8): 2621-2627
Tabarrini O; Manfroni G; Fravolini A; Cecchetti V; Sabatini S; et al.
Synthesis and anti-BVDV activity of acridones as new potential antiviral agents
00
6914837 2006 HEPATOLOGY 43 (3): 592-601
Tarr AW; Owsianka AM; Timms JM; McClure CP; Brown RJP; et al.
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
00
70419627 2006 ANTIVIRAL RESEARCH 69 (3): 129-141
Thimme R; Lohmann V; Weber F
A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
00
#LCRNCRNode / Date / Journal / AuthorLCSGCS
7115024 2006 ANALYTICAL BIOCHEMISTRY 350 (2): 239-248
Tonary AM; Pezacki JP
Simultaneous quantitative measurement of luciferase reporter activity and cell number in two-and three-dimensional cultures of hepatitis C virus replicons
00
72122128 2006 ANTIVIRAL THERAPY 11 (3): 273-287
Trepanier JB; Tanner JE; Alfieri C
Oligonucleotide-based therapeutic options against hepatitis C virus infection
00
7315058 2006 JOURNAL OF VIROLOGY 80 (4): 1734-1741
Tscherne DM; Jones CT; Evans MJ; Lindenbach BD; McKeating JA; et al.
Time-and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry
44
7414640 2006 HEPATOLOGY 43 (5): 932-942
von Hahn T; Lindenbach BD; Boullier A; Quehenberger O; Paulson M; et al.
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
11
7532970 2006 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (7): 2310-2315
Yi M; Villanueva RA; Thomas DL; Wakita T; Lemon SM
Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells
11

Generated by HistCite 2006.08.02